These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3094926)

  • 41. [General schema for safety evaluation of residues of embryotoxic drugs (author's transl)].
    Delatour P; Boisseau J; Burgat V; Mergier P; Milhaud G; Richou-Bac L; Rico A; Siou G
    Ann Rech Vet; 1981; 12(2):215-8. PubMed ID: 7342838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The susceptibility of the fetus and child to chemical pollutants. How environmental effects on child health are recognized.
    Miller RW
    Pediatrics; 1974 May; 53(5):792-9. PubMed ID: 4416524
    [No Abstract]   [Full Text] [Related]  

  • 43. [How to assess the risk of drugs?].
    Roujeau JC
    Ann Dermatol Venereol; 1998 Oct; 125(10):673-5. PubMed ID: 9835953
    [No Abstract]   [Full Text] [Related]  

  • 44. The "Telefono Rosso": a service for the prevention of birth defects and for the evaluation of teratogenic risk.
    Mastroiacovo P; Serafini M; Pagano M; De Santis M; Vercillo I; Celestini E
    Ann Ist Super Sanita; 1993; 29(1):115-20. PubMed ID: 8129257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The way women perceive teratogenic risk.
    Koren G
    Can J Clin Pharmacol; 2007; 14(1):e10-6. PubMed ID: 17213504
    [No Abstract]   [Full Text] [Related]  

  • 46. Azathioprine teratogenicity: review of the literature and case report.
    Williamson RA; Karp LE
    Obstet Gynecol; 1981 Aug; 58(2):247-50. PubMed ID: 7196003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Methods of evaluation of risks tied to drug exposure during pregnancy. Advantages and limits of epidemiology, interpretation of results].
    Robert-Gnansia E
    Therapie; 2002; 57(2):175-80. PubMed ID: 12185967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Preventive measures for the prevention of congenital abnormalities in epileptics].
    Kreybig T; Jüntgen HL
    Dtsch Z Mund Kiefer Gesichtschir; 1984; 8(3):172-5. PubMed ID: 6597023
    [No Abstract]   [Full Text] [Related]  

  • 49. [Methods for studying drug risk during pregnancy].
    Autret-Leca E; Jonville-Béra AP; Cissoko H
    Arch Pediatr; 2000 May; 7 Suppl 2():404s-406s. PubMed ID: 10904789
    [No Abstract]   [Full Text] [Related]  

  • 50. Teratogenicity tests and behavior.
    Dobbing J
    Lancet; 1982 Sep; 2(8298):604-5. PubMed ID: 6125742
    [No Abstract]   [Full Text] [Related]  

  • 51. [Preclinical trials for predicting fetal risk].
    Guittin P
    Arch Pediatr; 2000 May; 7 Suppl 2():401s-403s. PubMed ID: 10904788
    [No Abstract]   [Full Text] [Related]  

  • 52. [Studies on the teratogenicity of sodium pentachlorophenol in rats].
    Zhonghua Yu Fang Yi Xue Za Zhi; 1979; 13(1):8-10. PubMed ID: 552977
    [No Abstract]   [Full Text] [Related]  

  • 53. Risk management and monitoring methods for the future mother, embryo, fetus, and post-natal consequences.
    Jacqz-Aigrain E; Lamarque V
    Therapie; 2006; 61(4):297-304, 287-95. PubMed ID: 17124946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [What is the aim of uncontrolled phase IV studies on efficacy?].
    de Abajo FJ; Frías J; Garijo B; Lopo CR
    Med Clin (Barc); 1989 Jun; 93(1):38-9. PubMed ID: 2770375
    [No Abstract]   [Full Text] [Related]  

  • 55. Regulating teratogenicity as a health risk.
    Gilden N; Bodewitz H
    Soc Sci Med; 1991; 32(10):1191-8. PubMed ID: 2068602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the teratogenicity of fluorescein sodium.
    McEnerney JK; Wong WP; Peyman GA
    Am J Ophthalmol; 1977 Dec; 84(6):847-50. PubMed ID: 596400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lithium teratogenicity.
    Schou M; Amdisen A
    Lancet; 1971 May; 1(7709):1132. PubMed ID: 4102651
    [No Abstract]   [Full Text] [Related]  

  • 58. Studying the safety of ribavirin in human pregnancy.
    Koren G
    Pediatr Infect Dis J; 1990 Sep; 9(9 Suppl):S106-7. PubMed ID: 2235203
    [No Abstract]   [Full Text] [Related]  

  • 59. A followup study of children exposed to gold compounds in utero.
    Tarp U; Graudal H
    Arthritis Rheum; 1985 Feb; 28(2):235-6. PubMed ID: 3970738
    [No Abstract]   [Full Text] [Related]  

  • 60. Exploring protection from methotrexate-induced teratogenicity in flies.
    Wolfgang WJ
    Toxicol Sci; 2007 Oct; 99(2):363-5. PubMed ID: 17974061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.